BRGX (BioRegenx) OCF Margin %: 6.34% (As of Mar. 2026)


What is BioRegenx OCF Margin %?

BioRegenx BRGX OCF Margin % is 6.34% as of Mar. 2026. The stock has 5 warning signs investors should review. Among 669 Healthcare Providers & Services companies, BioRegenx ranks worse than 70.1% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. BioRegenx's Cash Flow from Operations for the three months ended in Mar. 2026 was $0.03 Mil. BioRegenx's Revenue for the three months ended in Mar. 2026 was $0.43 Mil. Therefore, BioRegenx's OCF Margin % for the quarter that ended in Mar. 2026 was 6.34%.

As of today, BioRegenx's current OCF Yield % is 0.38%.

The historical rank and industry rank for BioRegenx's OCF Margin % or its related term are showing as below:

BRGX' s OCF Margin % Range Over the Past 10 Years
Min: -154.76   Med: -34.95   Max: 2.1
Current: 1.59


During the past 12 years, the highest OCF Margin % of BioRegenx was 2.10%. The lowest was -154.76%. And the median was -34.95%.

BRGX's OCF Margin % is ranked worse than
70.1% of 669 companies
in the Healthcare Providers & Services industry
Industry Median: 8.29 vs BRGX: 1.59


BioRegenx OCF Margin % Related Terms


BioRegenx OCF Margin % Historical Data

* Premium members only.

The historical data trend for BioRegenx's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioRegenx OCF Margin % Chart

BioRegenx Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -60.30 -154.76 -44.42 -13.85 2.10

BioRegenx Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.38 0.67 -14.17 18.13 6.34

BRGX vs ACON, MGRX, WLSS: OCF Margin % Comparison

For the Health Information Services subindustry, BioRegenx's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioRegenx OCF Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BioRegenx's OCF Margin % distribution charts can be found below:

* The bar in red indicates where BioRegenx's OCF Margin % falls into.



BioRegenx OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

BioRegenx's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=0.039/1.855
=2.10 %

BioRegenx's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0.027/0.426
=6.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 6.34% mean?
BioRegenx (BRGX) has a OCF Margin % of 6.34% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on BioRegenx and its competitors. According to the industry distribution chart, BioRegenx ranks #469 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 70.1%.
Is BioRegenx's OCF Margin % too high?
BioRegenx's current OCF Margin % is 6.34%. The Healthcare Providers & Services industry median OCF Margin % is 8.29. BioRegenx's value of 6.34% is 23.5% below this industry median. Based on the distribution chart, BioRegenx ranks #469 out of 669 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does BioRegenx's OCF Margin % compare to ACON and MGRX?
According to the Healthcare Providers & Services industry distribution chart, BioRegenx ranks #469 out of 669 companies for OCF Margin %. This places BioRegenx in the lower half of its industry. The industry median OCF Margin % is 8.29. BioRegenx's value of 6.34% is 23.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.29, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioRegenx's current OCF Margin % of 6.34% is 23.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on BioRegenx and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioRegenx's current OCF Margin % is 6.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioRegenx stock overvalued right now?
Based on GuruFocus' analysis, BioRegenx (BRGX) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading 24% below its estimated fair value. The current OCF Margin % is 6.34% and 23.5% below the Healthcare Providers & Services industry median of 8.29. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For BioRegenx (BRGX), the current OCF Margin % is 6.34% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioRegenx Business Description

Address 7407 Ziegler Road, Chattanooga, TN, USA, 37421
BioRegenx Inc develops and manufactures medical test equipment and high-quality, science-based nutritional products. The Company distributes wellness devices. The products are sold nationally through a direct selling channel to health professionals and research organizations. The company operates and manages its business as one reportable and operating segment as a medical testing, diagnostic and nutraceutical company. It focuses on commercialization of its patented technologies in its field.